Shares of iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report) traded down 2.7% during trading on Friday . The stock traded as low as $34.79 and last traded at $34.79. 314 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 1,827 shares. The stock had previously closed at $35.77.
iShares Neuroscience and Healthcare ETF Trading Down 2.7%
The firm’s fifty day moving average price is $33.44 and its 200 day moving average price is $32.21. The firm has a market capitalization of $5.22 million, a PE ratio of 15.61 and a beta of 0.77.
iShares Neuroscience and Healthcare ETF Company Profile
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.
Featured Stories
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
